243 related articles for article (PubMed ID: 21731484)
41. Male genital tract immune response against
Mackern-Oberti JP; Motrich RD; Damiani MT; Saka HA; Quintero CA; Sánchez LR; Moreno-Sosa T; Olivera C; Cuffini C; Rivero VE
Reproduction; 2017 Oct; 154(4):R99-R110. PubMed ID: 28878094
[No Abstract] [Full Text] [Related]
42. Chlamydia trachomatis: TLR4-mediated recognition by human dendritic cells is impaired following oestradiol treatment.
Agrawal T; Bhengraj AR; Vats V; Mittal A
Br J Biomed Sci; 2013; 70(2):51-7. PubMed ID: 23888605
[TBL] [Abstract][Full Text] [Related]
43. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.
Lu H; Yang X; Takeda K; Zhang D; Fan Y; Luo M; Shen C; Wang S; Akira S; Brunham RC
Mol Med; 2000 Jul; 6(7):604-12. PubMed ID: 10997341
[TBL] [Abstract][Full Text] [Related]
44. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection.
Lampe MF; Wilson CB; Bevan MJ; Starnbach MN
Infect Immun; 1998 Nov; 66(11):5457-61. PubMed ID: 9784557
[TBL] [Abstract][Full Text] [Related]
45. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.
Perry LL; Su H; Feilzer K; Messer R; Hughes S; Whitmire W; Caldwell HD
J Immunol; 1999 Mar; 162(6):3541-8. PubMed ID: 10092812
[TBL] [Abstract][Full Text] [Related]
46. Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections.
Aiyar A; Quayle AJ; Buckner LR; Sherchand SP; Chang TL; Zea AH; Martin DH; Belland RJ
Front Cell Infect Microbiol; 2014; 4():72. PubMed ID: 24918090
[TBL] [Abstract][Full Text] [Related]
47. Chlamydia trachomatis regulates innate immune barrier integrity and mediates cytokine and antimicrobial responses in human uterine ECC-1 epithelial cells.
Mukura LR; Hickey DK; Rodriguez-Garcia M; Fahey JV; Wira CR
Am J Reprod Immunol; 2017 Dec; 78(6):. PubMed ID: 28921726
[TBL] [Abstract][Full Text] [Related]
48. Stromal Fibroblasts Drive Host Inflammatory Responses That Are Dependent on Chlamydia trachomatis Strain Type and Likely Influence Disease Outcomes.
Jolly AL; Rau S; Chadha AK; Abdulraheem EA; Dean D
mBio; 2019 Mar; 10(2):. PubMed ID: 30890604
[No Abstract] [Full Text] [Related]
49. Fc receptor regulation of protective immunity against Chlamydia trachomatis.
Moore T; Ananaba GA; Bolier J; Bowers S; Belay T; Eko FO; Igietseme JU
Immunology; 2002 Feb; 105(2):213-21. PubMed ID: 11872097
[TBL] [Abstract][Full Text] [Related]
50. PD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis.
Fankhauser SC; Starnbach MN
J Immunol; 2014 Feb; 192(3):1079-90. PubMed ID: 24353266
[TBL] [Abstract][Full Text] [Related]
51. Antigen-Specific CD4
Lin H; He C; Koprivsek JJ; Chen J; Zhou Z; Arulanandam B; Xu Z; Tang L; Zhong G
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962403
[TBL] [Abstract][Full Text] [Related]
52. IRG and GBP host resistance factors target aberrant, "non-self" vacuoles characterized by the missing of "self" IRGM proteins.
Haldar AK; Saka HA; Piro AS; Dunn JD; Henry SC; Taylor GA; Frickel EM; Valdivia RH; Coers J
PLoS Pathog; 2013; 9(6):e1003414. PubMed ID: 23785284
[TBL] [Abstract][Full Text] [Related]
53. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.
Morrison RP; Feilzer K; Tumas DB
Infect Immun; 1995 Dec; 63(12):4661-8. PubMed ID: 7591120
[TBL] [Abstract][Full Text] [Related]
54. Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.
Karunakaran KP; Yu H; Jiang X; Chan QWT; Foster LJ; Johnson RM; Brunham RC
J Infect Dis; 2020 Feb; 221(5):841-850. PubMed ID: 31599954
[TBL] [Abstract][Full Text] [Related]
55. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
Rey-Ladino J; Ross AG; Cripps AW
Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
[TBL] [Abstract][Full Text] [Related]
56. Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis.
Perry LL; Feilzer K; Hughes S; Caldwell HD
Infect Immun; 1999 Mar; 67(3):1379-85. PubMed ID: 10024585
[TBL] [Abstract][Full Text] [Related]
57. A Chlamydia trachomatis Strain Expressing Ovalbumin Stimulates an Antigen-Specific CD4
Helble JD; Starnbach MN
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 30988057
[TBL] [Abstract][Full Text] [Related]
58. Antibody, but not B-cell-dependent antigen presentation, plays an essential role in preventing Chlamydia systemic dissemination in mice.
Malaviarachchi PA; Mercado MAB; McSorley SJ; Li LX
Eur J Immunol; 2020 May; 50(5):676-684. PubMed ID: 32026472
[TBL] [Abstract][Full Text] [Related]
59. CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.
Meoni E; Faenzi E; Frigimelica E; Zedda L; Skibinski D; Giovinazzi S; Bonci A; Petracca R; Bartolini E; Galli G; Agnusdei M; Nardelli F; Buricchi F; Norais N; Ferlenghi I; Donati M; Cevenini R; Finco O; Grandi G; Grifantini R
Infect Immun; 2009 Sep; 77(9):4168-76. PubMed ID: 19596772
[TBL] [Abstract][Full Text] [Related]
60. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
Agrawal T; Vats V; Salhan S; Mittal A
J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
